COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,596 Articles (22,905 medRxiv, 8,691 bioRxiv)

Most recent first Previous |  Page 1241: Articles 12401-12410  | Next

Predicting the unpredictable: how dynamic COVID-19 policies and restrictions challenge model forecasts
Houdroge, F., Palmer, A., Delport, D., Walsh, T., Kelly, S. L., Hainsworth, S. W., Abeysuriya, R. G., Stuart, R. M., Kerr, C. C., Coplan, P., Wilson, D. P., Scott, N.
10.1101/2021.09.30.21264273 — Posted: 2021-10-01
Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
Lee, A. R. Y. B., Wong, S. Y., Chai, L. Y. A., Lee, S. C., Lee, M., Muthiah, M. D., Tay, S. H., Teo, C. B., Tan, B. K. J., Chan, Y. H., Sundar, R., Soon, Y. Y.
10.1101/2021.09.28.21264126 — Posted: 2021-10-01
Humoral and cellular immune responses upon SARS-CoV-2 vaccines in patients with anti-CD20 therapies: A systematic review and meta-analysis of 1342 patients
Schietzel, S., Anderegg, M., Limacher, A., Born, A., Horn, M., Maurer, B., Hirzel, C., Sidler, D., Moor, M. B.
10.1101/2021.09.30.21264335 — Posted: 2021-10-01
Equivalence of saliva RT-qPCR testing to nasal-throat/nasopharyngeal swab testing in the general practitioner's setting to detect SARS-CoV-2
Jonckheere, I., Faes, L., Overmeire, Y., De Vleeschauwer, A., Vanden Daele, L., Van Bruaene, N., Vandecandelaere, I., Merlaen, B., van Cann, J., Vandesompele, J.
10.1101/2021.09.30.21264181 — Posted: 2021-10-01
ViralFlow: an automated workflow for SARS-CoV-2 genome assembly, lineage assignment, mutations and intrahost variants detection
Dezordi, F. Z., Campos, T. d. L., Jeronimo, P. M. C., Aksenen, C. F., Almeida, S. P., Wallau, G. L.
10.1101/2021.10.01.21264424 — Posted: 2021-10-01
Immune Memory Response After a Booster Injection of mRNA-1273 for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Chu, L., Montefiori, D., Huang, W., Nestorova, B., Chang, Y., Carfi, A., Edwards, D. K., Oestreicher, J., Legault, H., Girard, B., Pajon, R., Miller, J. M., Das, R., Leav, B., McPhee, R.
10.1101/2021.09.29.21264089 — Posted: 2021-10-01 Discussion: Onsite
Longitudinal SARS-CoV-2 testing is punctuated by intermittent positivity and variable rates of cycle-threshold decline
Hawken, S. E., Sellers, S. A., Smedberg, J. R., Ward, J. D., Whinna, H. C., Fischer, W. A., Miller, M. B.
10.1101/2021.10.01.21264373 — Posted: 2021-10-01
Adaptive data-driven age and patch mixing in contact networks with recurrent mobility
Knight, J., Ma, H., Ghasemi, A., Hamilton, M., Brown, K., Mishra, S.
10.1101/2021.09.29.21264319 — Posted: 2021-10-01
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinations
Anderson, E. M., Eiloa, T., Goodwin, E., Bolton, M. J., Gouma, S., Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Dunbar, D., Fiore, D., Brock, A., Weaver, J., Millar, J. S., DerOhannessian, S., The UPenn COVID Processing Unit, , Greenplate, A. R., Frank, I., Rader, D. J., Wherry, E. J., Hensley, S. E.
10.1101/2021.09.30.21264363 — Posted: 2021-10-01 Discussion: Onsite
A HOME-TREATMENT ALGORITHM BASED ON ANTI-INFLAMMATORY DRUGS TO PREVENT HOSPITALIZATION OF PATIENTS WITH EARLY COVID-19: A MATCHED-COHORT STUDY (COVER 2)
Consolaro, E., Suter, F., Rubis, N., Pedroni, S., Moroni, C., Pasto, E., Paganini, M. V., Pravettoni, G., Cantarelli, U., Perico, N., Perna, A., Peracchi, T., Ruggenenti, P., Remuzzi, G.
10.1101/2021.09.29.21264298 — Posted: 2021-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).